Phosphate Binders in CKD: ‟New Kids on the Block”
DOI :
https://doi.org/10.53778/pjkd31089Mots-clés :
hyperphosphatemia, mineral bone disease, sevelamer, ferric sitrate, lanthanum, sucro ferricoxyhydroxideRésumé
Phosphate control is essential component of dietary and medical management of chronic kidney disease (CKD) patients. Hyperphosphatemia has a significant effect on morbidity and mortality of CKD patients. This review takes us through the different older and newer medications available for management of hyperphosphatemia.
Téléchargements
Publiée
Numéro
Rubrique
Licence
Merci de créditer les auteurs lors de toute citation : Muhammad Umair Afzal, Shafeeq Cheema (2021)

Ce travail est disponible sous licence Creative Commons Attribution - Pas d’Utilisation Commerciale 4.0 International.
